The Prevalence and Concurrent Pathogenic Mutations of KRAS G12C in Northeast Chinese Non-small-cell Lung Cancer Patients - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33758543/

1 Medical Oncology Translational Research Lab, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital, Changchun, 130012, People's Republic of China. 2 Department of Medical Thoracic Oncology, Jilin Cancer Hospital, Changchun, 130012, People's Republic of China. 3 Department of Bioinformatics, Burning Rock Biotech, Guangzhou, People's Republic of China.